Explore peer-reviewed publications from A5 collaborators and member institutions advancing adrenal tumor research.
Researchers across A5 are producing groundbreaking work in adrenal tumor science —here are a few featured publications that highlight the impact of our global collaboration.
The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 9, September 2024
To investigate the contributions of renin-independent aldosteronism and ACTH-mediated aldosteronism in individuals with a low-renin phenotype representing the entire continuum of blood pressure.
Hypertension, Volume 81, Number 3, January 2024
Primary aldosteronism (PA) has been broadly dichotomized into unilateral and bilateral forms. Adrenal vein sampling (AVS) lateralization indices (LI) ≥2 to 4 are the standard-of-care to recommend unilateral adrenalectomy for presumed unilateral PA. We aimed to assess the rates and characteristics of residual PA after AVS-guided adrenalectomy.
To explore the full scope of our scientific contributions, including the most recent peer-reviewed studies from A5-affiliated researchers, visit our dedicated PubMed listing for a comprehensive and up-to-date collection of publications.
A5 is a growing organization made up of clinicians, researchers, trainees, students, and advocates from more than 50 major academic and research centers in the three continents. Support adrenal research and become part of a growing global network!
